AbbVie Outlines Long-Term Strategic and Financial Objectives; Company Positioned for Strong Performance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
UBS Reiterates Buy on AbbVie (ABBV) Following Conference Call
November 2, 2015 9:58 AM ESTUBS reiterated a Buy rating and $78.00 price target on Abbvie (NYSE: ABBV) following the company's conference call. Management assumes no biosimiliars before 2022, and low mid-single digit annual price increases. On Humira biosimilar, management believes US biosimilars will likely infringe its dosing patents as they have to demonstrate efficacy at equal dosing.
Analyst... More
AbbVie (ABBV) Reports Strong 3Q and Long term outlook; Cowen Reiterates Outperform
October 30, 2015 1:23 PM EDTCowen reiterated an Outperform rating and $77.00 price target on Abbvie (NYSE: ABBV) following the company's 3Q earnings results. Q3 EPS of $1.13 was $0.06 above consensus. Full year guidance has been raised to $4.26-4.28 (prior $4.10-4.30). Q3 sales of $5,944MM (+18%) were $54MM above... More
AbbVie (ABBV) Raises Quarterly Dividend 11.8% to $0.57; 4.2% Yield
October 30, 2015 6:57 AM EDTAbbVie (NYSE: ABBV) declared a quarterly dividend of $0.57 per share, or $2.28 annualized. This is an 11.8% increase from the prior dividend of $0.51.
The dividend will be payable on February 16, 2016, to stockholders of record on January 15, 2016, with an ex-dividend date of January 13,... More
AbbVie (ABBV) Issues Long-Term Outlook; Boosts Qtr. Dividend
October 30, 2015 6:55 AM EDTAbbVie (NYSE: ABBV) outlined the company's long-term strategic and financial objectives, including expectations for growth and other financial metrics over its long-range plan, through 2020.
"AbbVie is well-positioned to deliver strong top- and bottom-line performance through 2020 and beyond," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "We have built a strong foundation, establishing growth platforms in some of the largest and most attractive market segments. And, we have a robust and compelling pipeline which will contribute significantly to our performance over our long-range-plan."
Based on continued strong performance from its existing... More
